Skip to main content
Premium Trial:

Request an Annual Quote

Circular Genomics: Michael Ackermann

Circular Genomics appointed Michael Ackermann to its scientific advisory board. Ackermann previously served as SVP of Quintiles and cofounded the angel fund AB Collaborative Investment, where he also serves as president. Ackermann has held multiple positions as a member of the board of directors or consultant to Fortune 500 and start-up companies in the biopharma sector. Since 2015, he has been serving as cofounder, board member, and chief business officer at Arrivo BioVentures. Ackermann began his career at Eli Lilly and Company.